16 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Cmpds
Data
Article Title
Organization
511
MK2 INHIBITORS AND METHODS OF MAKING AND USING THE SAME

Gilead Sciences
6
ERGOLINE-DERIVED AGONISTS OF THE 5-HT2A RECEPTOR

Diamond Therapeutics Inc.
392
IMIDAZOLO INDAZOLE COMPOUNDS AS JAK INHIBITORS

Theravance Biopharma R&D Ip
16
Anti-cancer nuclear hormone receptor-targeting compounds

Nuvation Bio
15
2-beta-naphthyl-acetic acid analogs as AKR1C3 inhibitors and methods of using same

The Trustees of The University of Pennsylvania
19
Class of amino-substituted nitrogen-containing fused ring compounds, preparation method therefor, and use thereof

Shanghai Ringene Biopharma
713
2-oxoquinazoline derivatives as methionine adenosyltransferase 2A inhibitors

Ideaya Biosciences
83
2-aryl- and 2-heteroaryl-substituted 2-pyridazin-3(2H)-one compounds as inhibitors of FGFR tyrosine kinases

Array Biopharma
9
Composition for suppressing neuraminidase activity comprising geranylated flavonoid derived from Paulownia tomentosa as active ingredient

Industry-Academic Cooperation Foundation Gyeongsang National University
25
Substituted imidazopyridazines

Bayer Intellectual Property
14
Antagonists of prostaglandin EP3 receptor

Pfizer
541
Inhibitors of beta-secretase

Vitae Pharmaceuticals
1
Monoacylglycerol lipase inhibitors for the treatment of metabolic diseases and related disorders

Janssen Pharmaceutica
189
Substituted imidazo[1,2-a]pyrimidines and —pyridines

Bayer Intellectual Property
4
(4-{4-[5-(benzooxazol-2-ylamino)-pyridin-2-yl]-phenyl}-cyclohexyl)-acetic acid useful for treating or preventing conditions or disorders associated with DGAT1 activity

Novartis
120
Benzenesulfonamide derivatives as inverse agonists of retinoid-related orphan receptor gamma (RORγ(T))

Galderma Research & Development